Industry observers eye Torti as potential FDA commissioner

06/16/2008 | TheRPMReport.com

Industry experts say Frank Torti could be the successor to FDA Commissioner Andrew von Eschenbach, who is expected to leave the post after the November elections. Torti outlined a plan for his first 100 days as FDA's chief scientist at an FDA Science Board appearance, giving insight into his policy plans at the agency. A partial transcript is available here.

View Full Article in:

TheRPMReport.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA